Results 111 to 120 of about 126,270 (309)

The influence of cannabis use expectancies on cannabis use and psychotic symptoms in psychosis

, 2008
Introduction and Aims: Little is known about motives or expectancies for cannabis use in psychotic populations, despite these cognitive factors being a central focus of the treatment for substance misuse in psychosis. This study examined the relationship
Kavanagh, David J., J. Kavanagh, David, Young, Ross McD, Kavanagh, David J, Dawe, Sharon, Hides, Leanne, Young, Ross. McD., Young, Ross McD.   +7 more
core   +1 more source

Genomic Insights Into Risperidone Treatment Outcomes in Children and Adolescents: Experience From a Psychiatric Hospital Serving Rural Youth

Clinical Pharmacology &Therapeutics, EarlyView.
Risperidone is a commonly used antipsychotic for treating psychiatric illness in children and adolescents. There is a large variability in risperidone response and discontinuation rates remain high. Pharmacogenomics offers the opportunity to improve risperidone outcomes, yet studies in pediatric populations are limited.
Jack W. Staples, Shayna R. Killam, Karen E. Brown, Rachel Dalton, Elizabeth Sather, Qiang Chen, Joshua Loveland, Corbin Schwanke, Abdallah F. Elias, Kristin L. Bigos, Erica L. Woodahl   +10 more
wiley   +1 more source

Stimulant medication and psychotic symptoms in offspring of parents with mental illness

, 2016
BACKGROUND: Stimulants, such as methylphenidate, are among the most commonly used medications in children and adolescents. Psychotic symptoms have been reported as rare adverse reactions to stimulants but have not been systematically inquired about in ...
Cumby, Jill, Fisher, Helen L., Morash-Conway, Jessica, Propper, Lukas, Hajek, T., Cumby, J., Propper, L., Bagnell, A., Hajek, Tomas, MacKenzie, Lynn E., Abidi, Sabina, Pajer, K., Alda, M., Fisher, H. L., Schultze-Lutter, Frauke, Uher, Rudolf, Glover, Jacqueline M., Bagnell, Alexa, Pajer, Kathleen, Uher, R., Morash-Conway, J., Alda, Martin, Glover, J. M., MacKenzie, L. E., Abidi, S.   +24 more
core   +1 more source

Cannabidiol in Anorexia Nervosa: A Double‐Blind Randomized Placebo Controlled Pilot Study to Test Safety, Pharmacokinetics, and Symptom Change

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Anorexia nervosa (AN) is a severe psychiatric disorder marked by an intense fear of gaining weight and persistent body dissatisfaction, both during periods of underweight and after weight restoration. The endocannabinoid system may offer therapeutic benefits, particularly in reducing anxiety.
Neha Sahota, David J. Grelotti, Tyler Nguyen, Walter H. Kaye, Skylar Swindle, Raymond Suhandynata, Spencer Seely, Megan E. Shott, Guido K. W. Frank   +8 more
wiley   +1 more source

Buprenorphine-Induced Psychotic Symptoms:

The Primary Care Companion For CNS Disorders, 2013
To the Editor: Buprenorphine has been available in the market since the 1980s as an analgesic. It was approved by the US Food and Drug Administration (FDA) for use in opioid addiction in October 2002. Since then, most studies have found buprenorphine to be well tolerated with the added advantage of having a ceiling effect as compared to other opioids ...
Sannidhya, Varma, Srinivas, Balachander, Debasish, Basu   +2 more
openaire   +3 more sources

Neurosyphilis with psychotic symptoms and Parkinsonism in a young girl

, 2015
Li Yin,* Shoukang Zou,* Yi Huang Department of Psychiatry, West China Hospital of Sichuan University, Chengdu, People’s Republic of China *These authors contributed equally to this work Abstract: A 15-year-old girl with neurosyphilis was ...
Huang Y, Zou S, Yin L
core  

Feasibility and Preliminary Efficacy of a Guided Self‐Help Digital Intervention for Adults With Food Insecurity, Recurrent Binge Eating, and Type 2 Diabetes Mellitus: A Pilot Trial

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Food insecurity is increasingly linked to binge eating and weight‐related health issues like type 2 diabetes mellitus, but no eating disorder interventions have been tested among individuals with food insecurity. We conducted a single‐arm pilot test of FoodSteps‐FI, a guided self‐help digital intervention for binge eating adapted for
Andrea K. Graham, Rebecca L. Flynn, Isabel R. Rooper, Chidiebere Azubuike, Lindsay D. Lipman, Adrian Ortega, Leah M. Parsons, Graham C. Miller, Damien Lekkas, Jennifer E. Wildes   +9 more
wiley   +1 more source

Epidemiological Characteristics and Risk Factors of Methamphetamine—Associated Psychotic Symptoms

Frontiers in Psychiatry, 2018
Objective: To explore the epidemiological characteristics and the risk factors for methamphetamine (MA)—associated psychotic symptoms among MA users in China.Methods: A cross-sectional study was conducted between April, 2012 and October, 2015 among ...
Meng-Fan Su, Meng-Fan Su, Mo-Xuan Liu, Mo-Xuan Liu, Jin-Qiao Li, Jin-Qiao Li, Julia M. Lappin, Su-xia Li, Ping Wu, Ping Wu, Zhi-Min Liu, Jie Shi, Lin Lu, Lin Lu, Yanping Bao, Yanping Bao   +15 more
doaj   +1 more source

Aripiprazole for the treatment of psychotic symptoms in patients with dementia with Lewy bodies: a case series [PDF]

, 2019
Yuka Sugawara Kikuchi, Tetsuo ShimizuDepartment of Neuropsychiatry, Akita University Graduate School of Medicine, Akita 010-8543, JapanPurpose: The core features of dementia with Lewy bodies (DLB) are cognitive fluctuations, visual hallucinations, and ...
Sugawara Kikuchi Y, Shimizu T
core  

Daily Body (Dis‐)Satisfaction and Dietary Restriction in Women Across the Eating Disorder Spectrum

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Body dissatisfaction is a key risk factor in eating disorder development: It is theorized to promote dietary restriction, thereby contributing to symptom onset. Evidence for this pathway primarily comes from cross‐sectional or multi‐wave questionnaire studies in bulimia nervosa (BN) and anorexia nervosa (AN).
Michaela R. Buehler, Ann‐Kathrin Arend, Julia Reichenberger, Jens Blechert   +3 more
wiley   +1 more source